Stockreport

Sonoma Pharmaceuticals Announces Second FDA Approval to Add Antimicrobial Language to Alevicyn™ Gel Products for Management of Atopic Dermatitis

Sonoma Pharmaceuticals, Inc.  (SNOA) 
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sonomapharma.com
PDF PETALUMA, Calif., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and m [Read more]